Description:
Introduction: There is just few data available regarding the prophylaxis of thromboembolic disease in patients under palliative care. The decision for an anticoagulant treatment is complex and needs to be in balance between medical and patient-centered aspects. The coherence between malignant disease and venous thromboembolism (VTE) is well known. Opposed to internal medicine or oncology, in 2009 there were no clear treatment standards for patients in palliative care - and for Germany there were no information existing concerning the distribution of VTE-prophylaxis in palliative patients, t...